The Food and Drug Administration (FDA) has approved the handheld ultrasound device, SONON 300L, for use by primary care providers (PCPs). The device is indicated for ultrasound echo imaging, measurement, and analysis of the human body for general clinical applications including musculoskeletal, vascular, small parts (breast, thyroid), and lung imaging.
SONON 300L works in tandem with an app that displays the images for analysis on both tablets and smartphones. The device, which weighs just 13 ounces, has a rechargeable, lithium ion-battery (3-hour continuous scanning battery life),
WiFi connectivity and 3G/LTE cellular capability. It also supports medical imaging protocols including DICOM (Digital Imaging and Communications in Medicine) and PACS (Picture Archiving and Communication System).
“It [SONON 300L] allows PCPs to be more efficient and effective with instant insight to diagnose or refer a patient to a specialist,” said Healcerion founder and CEO, Dr Benjamin Jeongwon Ryu, MD.
The Company foresees the device also being used in retail clinics, urgent care centers, mini-hospitals, and in rural and third-world regions.
For more information visit Healcerion.com.
This article originally appeared on MPR